Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Mark These Tax-loss Selling Dates on Your Calendar (Updated 2024)

13 Canadian Crypto ETFs (Updated 2024)

Investing in Graphene Companies (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

10 Top Oil-producing Countries (Updated 2024)

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

A State-by-State Guide to Cannabis in Australia (Updated 2024)

When is the Starlink IPO Date and Can You Invest? (Updated 2024)

Trending Press Releases

Radiopharm achieves Nasdaq listing of ADS

Mawson Finland Limited Identifies Compelling Soil Geochemical Targets for Follow-Up

Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence

First Helium Provides Year End Corporate Update

Mines and Money Miami Returns for Its Third Edition

RAD 202 receives approval to start Phase 1 therapeutic trial

More Press Releases
Trending Companies

First Helium

HELI:CA

Black Swan Graphene

SWAN:CC

Metals Australia

MLS:AU

Soma Gold Corp.

SOMA:CA
More Companies
Trending Reports

2025 Gold Outlook Report

2025 Uranium Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

2024 Oil & Gas Outlook Report

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold Price
Silver Price
Copper Price
Oil Price
Uranium
Artificial Intelligence
loader

Mirum Pharmaceuticals Inc.

NASDAQ:MIRM:US
Press Releases

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Interactive Chart

×